The European Brain Council is pleased to invite you to register for the digital event “Patient safety and informed consent: The importance of good off-label use practices” to be held virtually on 17 June 2021 at 14:30 – 16:00CET. The event is co-organised with EUCOPE.

In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a coalition of European organisations dedicated to ensuring that high standards of patient care are upheld and that progress in medical research and innovation is achieved. The GOLUP Declaration recommends that off-label use of medicinal products should only occur if certain criteria, drawn together by independent experts, are met.

Five years later, the time has come to take a step forward, to look back at what has been achieved and to prepare for future developments. It becomes necessary not only to take an EU-wide view of the use of off-label medicines but also to take action at the national level.

The purpose of this event is to allow an exchange of ideas and experience among stakeholders and local actors, to understand which paths to take in individual Member States and to allow a continuous exchange of ideas and information on the off-label use of medicines.